Latest Insider Transactions at Horizon Therapeutics Public LTD CO (HZNP)
This section provides a real-time view of insider transactions for Horizon Therapeutics Public LTD CO (HZNP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Horizon Therapeutics Public Ltd Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Horizon Therapeutics Public Ltd Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 27
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Bona fide gift
|
Indirect |
8,531
+12.19%
|
-
|
|
May 27
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
8,531
-78.22%
|
-
|
|
May 20
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-5.15%
|
$2,250,000
$90.0 P/Share
|
|
May 20
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+4.9%
|
$550,000
$22.14 P/Share
|
|
May 11
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
17,600
-3.68%
|
$1,584,000
$90.0 P/Share
|
|
May 11
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,600
+3.55%
|
$387,200
$22.14 P/Share
|
|
May 06
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
7,400
-0.79%
|
$666,000
$90.72 P/Share
|
|
May 06
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,400
+1.56%
|
$162,800
$22.14 P/Share
|
|
May 02
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.74%
|
$2,400,000
$96.48 P/Share
|
|
Apr 29
2022
|
Gino Santini Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,658
-3.29%
|
$162,484
$98.56 P/Share
|
|
Apr 29
2022
|
Gino Santini Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,223
+7.72%
|
-
|
|
Apr 29
2022
|
James Samuel Shannon Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,658
-3.72%
|
$162,484
$98.56 P/Share
|
|
Apr 29
2022
|
James Samuel Shannon Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,223
+8.66%
|
-
|
|
Apr 29
2022
|
Jeff Himawan Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,139
-1.96%
|
$111,622
$98.56 P/Share
|
|
Apr 29
2022
|
Jeff Himawan Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,223
+6.76%
|
-
|
|
Apr 29
2022
|
William F Daniel Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,139
-1.45%
|
$111,622
$98.56 P/Share
|
|
Apr 29
2022
|
William F Daniel Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,223
+5.09%
|
-
|
|
Apr 29
2022
|
Michael G Grey Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,139
-1.71%
|
$111,622
$98.56 P/Share
|
|
Apr 29
2022
|
Michael G Grey Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,223
+5.97%
|
-
|
|
Apr 29
2022
|
Pascale Witz Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,658
-3.64%
|
$162,484
$98.56 P/Share
|
|
Apr 29
2022
|
Pascale Witz Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,223
+8.48%
|
-
|
|
Apr 29
2022
|
Thomas Watkins Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,223
+5.32%
|
-
|
|
Apr 29
2022
|
Susan Mahony Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,658
-9.07%
|
$162,484
$98.56 P/Share
|
|
Apr 29
2022
|
Susan Mahony Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,223
+18.77%
|
-
|
|
Apr 22
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.24%
|
$2,675,000
$107.61 P/Share
|
|
Apr 22
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+4.67%
|
$550,000
$22.14 P/Share
|
|
Apr 20
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Direct |
50,000
-75.55%
|
$5,700,000
$114.76 P/Share
|
|
Apr 20
2022
|
Paul W. Hoelscher EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+49.48%
|
$1,100,000
$22.14 P/Share
|
|
Apr 18
2022
|
Elizabeth H.Z. Thompson EVP, Research & Development |
SELL
Open market or private sale
|
Direct |
8,098
-38.28%
|
$931,270
$115.64 P/Share
|
|
Apr 12
2022
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
20,214
-10.38%
|
$2,284,182
$113.08 P/Share
|
|
Apr 08
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.48%
|
$2,800,000
$112.21 P/Share
|
|
Apr 08
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+4.67%
|
$550,000
$22.14 P/Share
|
|
Apr 06
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
42,009
-79.81%
|
$4,620,990
$110.02 P/Share
|
|
Apr 06
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Indirect |
91,710
-57.9%
|
$10,088,100
$110.01 P/Share
|
|
Apr 06
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Direct |
215,335
-99.52%
|
$23,686,850
$110.01 P/Share
|
|
Apr 06
2022
|
Paul W. Hoelscher EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
215,335
+47.62%
|
$4,091,365
$19.05 P/Share
|
|
Mar 30
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-4.76%
|
$5,250,000
$105.06 P/Share
|
|
Mar 25
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-4.46%
|
$2,725,000
$109.37 P/Share
|
|
Mar 25
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+4.27%
|
$550,000
$22.14 P/Share
|
|
Mar 25
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Indirect |
663
-0.42%
|
$72,930
$110.0 P/Share
|
|
Mar 24
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Indirect |
1,481
-0.92%
|
$162,910
$110.0 P/Share
|
|
Mar 23
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Indirect |
11,699
-6.79%
|
$1,286,890
$110.01 P/Share
|
|
Mar 23
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Direct |
26,090
-96.13%
|
$2,869,900
$110.0 P/Share
|
|
Mar 23
2022
|
Paul W. Hoelscher EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,090
+49.01%
|
$391,350
$15.96 P/Share
|
|
Mar 18
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,531
+13.95%
|
$187,682
$22.14 P/Share
|
|
Mar 11
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.25%
|
$2,525,000
$101.07 P/Share
|
|
Mar 11
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+4.27%
|
$550,000
$22.14 P/Share
|
|
Mar 10
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Bona fide gift
|
Indirect |
8,169
+13.37%
|
-
|
|
Mar 10
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
8,169
-15.63%
|
-
|
|
Mar 07
2022
|
Paul W. Hoelscher EVP, CFO |
BUY
Bona fide gift
|
Indirect |
238,852
+35.69%
|
-
|